Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: A randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy

European Journal of Heart Failure

Volumn 5, Issue 5, 2003, Pages 679-691

  Waagstein, F ^a   Stromblad O ^a   Andersson, B ^a   Bohm M ^b   Darius, M ^c   Delius, W ^d   Goss, F ^e   Osterziel, K J ^f   Sigmund, M ^g   Trenkwalder, S P ^h   Wahlqvist, I ⁱ  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAARLAND UNIVERSITY   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d KLINIKUM BOGENHAUSEN   (Germany)

^e Private Cardiologist Marienplatz 1   (Germany)

^f HUMBOLDT UNIVERSITY   (Germany)

^g DR HORST SCHMIDT KLINIKEN   (Germany)

^h UNIVERSITY OF MUNICH   (Germany)

ⁱ ASTRAZENECA   (United Kingdom)

Author keywords

Cardiomyopathy; Drugs; Exercise; Heart failure; Ischemia

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL; PLACEBO; RADIOISOTOPE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DIZZINESS; DOPPLER ECHOGRAPHY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSPNEA; EXERCISE; EXERCISE TEST; FATIGUE; FEMALE; GATED IMAGING; HEART; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE ISCHEMIA; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SCINTIANGIOGRAPHY; SCINTISCANNING; SIDE EFFECT; TIME; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; CARDIOMYOPATHY, DILATED; DOUBLE-BLIND METHOD; EXERCISE; EXERCISE TEST; FEMALE; GATED BLOOD-POOL IMAGING; HEART; HUMANS; MALE; METOPROLOL; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL ISCHEMIA; STROKE VOLUME; TIME FACTORS; VENTRICULAR REMODELING;

EID: 9144264195     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(03)00105-3     Document Type: Article

References (43)

1. Sharpe N, Murphy J, Smith H, Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 1988;1:255-9.
2. Sutton M, St J, Pfeffer MA, Plappert T, Rouleau J-L, Moyé LA, et al. For the SAVE Investigators. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effect of captopril. Circulation 1994;89:68-75.
3. CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomized trial. Lancet 1999;353:9-13.
4. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.
5. Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, Krum H, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 22 October, 2002;106(17):2194-9.
6. Waagstein F, Caidahl K, Wallentin I, Bergh CH, Hjalmarson Å. Long-term beta blockade in dilated cardiomyopathy. Effects of short-and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation 1989;80:551-63.
7. Australia-New Zealand Heart Failure Research Collaborative Group. Effect of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation 1995;92:212-8.
8. Doughty RN, Whalley GA, Gamble G, MacMahon S, Sharpe N. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Am Coll Cardiol 1997;29:1060-6.
9. Waagstein F, Bristow MR, Swedberg K. Beneficial effects of the metoprolol in idiopathic dilated cardiomyopathy (MDC) trial. A randomised, double-blind, placebo-controlled multicentre trial. Lancet 1993;342:1441-6.
10. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol 1995;25:1154-61.
11. Fisher ML, Gottlieb SS, Plotnick GD, Greenberg NL, Patten RD, Benneth SK, et al. Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial. J Am Coll Cardiol 1994;23:943-50.
12. Senior R, Basu S, Kinsey C, Schaeffer S, Lahiri A. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction. Am Heart J 1999;137:646-52.
13. Khattar RS, Senior R, Soman R, van der Does R, Lahiri A. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol. Am Heart J;142:704-713.
14. Groenning BA, Nilsson JC, Sondergaard L, Fritz-Hansen T, Larsson HBW, Hildebrandt PR. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol 2000;36:2072-80.
15. Dubach P, Myers J, Bonetti P, Schertler T, Froelicher V, Wagner D, et al. Effects of bisoprolol fumarate on left ventricular size, function and exercise capacity in patients with heart failure: Analysis with magnetic resonance myocardial tagging. Am Heart J 2002;143:676-83.
16. Ekman M, Lomsky M, Strömblad GO, Carlsson S. Closed-line integral optimization edge detection algorithm and its application in equilibrium radionuclide angiography. J Nucl Med 1995;36:1014-8.
17. Massardo T, Gal RA, Grenier RP, Schmidt DH, Port SC. Left ventricular volume calculation using a count-based ratio method applied to multigated radionuclide angiography. J Nucl Med 1990;31:450-6.
18. Woodley SL, Gilbert EM, Anderson JL, O'Connell JB, Detitchman D, Yanowitz FG, et al. Beta-blockade with bucindolol in heart failure due to ischemic versus idiopathic dilated cardiomyopthy. Circulation 1991;84:2426-41.
19. Figulla HR, Rahlf G, Nieger M, Luig H, Kreuzer H. Spontaneous hemodynamic improvement or stabilization and associated biopsy findings in patients with congestive cardiomyopathy. Circulation 1985;71:1095-104.
20. Palazzouli A, Bruni F, Pouccetti L, Pastorelli M, Angori P, Pasqui AL, et al. Effects of carvedilol on left ventricular remodelling and systolic function in elderly patients with heart failure. Eur J Heart Fail 2002;4:765-70.
21. Kuhlkamp V, Schirdewan A, Stangl K, Homberg M, Ploch M, Beck OA. Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 2000;36:139-46.
22. Regitz-Zagrosek V, Leuchs B, Krulls-Munch J, Fleck E. Angiotensin-converting enzyme inhibitors and beta-blockers in long-term treatment of dilated cardiomyopathy. Am Heart J 1985;129:754-61.
23. Vantrimpont P, Rouleau JL, Wun CC, Ciampi A, Klein M, Sussex B, et al. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the survival and ventricular enlargement (SAVE) study. Save investigators. J Am Coll Cardiol 1997;29:229-36.
24. Khattar SR, Senior R, Soman P, van der Does R, Lahiri A. Regression of left ventricular remodelling in chronic heart failure:comparative and combined effects of captopril and carvedilol. Am Heart J 2001;142:704-13.
25. Remme WJ. Carmen Steering Committee and Investigators. The Carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN)-rationale and design. Cardiovasc Drugs Ther 2001;15:9-10.
26. Coletta AP, Louis AA, Clark A, Nikitin N, Cleland JGF. Clinical trials update from the European Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II. Eur J Heart Fail 2002;4:661-6.
27. Yoshitomi Y, Kojima S, Michiko Y, Toshihiko S, Matsumotu Y, Kuramochi M. Long-term effects of bisoprolol com pared with imidapril on left ventricular remodeling after reperfusion in acute myocardial infarction: an angiographic study in patients with maintained vessel patency. Am Heart J 2000;140:e27.
28. Ricci R, Colletta C, Ceci V, Pajes G, Lucia R, Salustri A, et al. On behalf of RIMA Researchers. Effect of early treatment with capotopril and metoprolol singly and together on postinfarction left ventricular remodeling. Am Heart J 2001;142(4):E5.
29. Neglia D, Parodi O, Galoppin M, Sambuceti G, Giorgetti A, Pratali L, et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation 1995;92:796-804.
30. Buck JD, Hardman HF, Warltier DC, Garett JG. Changes in ischemic blood flow distribution and dynamic severity of coronary stenosis induced by beta blockade in canine heart. Circulation 1981;64:708-15.
31. Åblad B, Abrahamsson T, Adler G, Björkman J-A, Bjurö T, Ek L, et al. Cardiac anti-ischemic effects of metoprolol: role of beta-blockade within the ischemic region. J Cardiovasc Pharm 1987;10(suppl):S117-S125.
32. Gross DJ, Lamping KG, Warltier DC, Hardman HF. Effects of three bradycardic drugs on regional myocardial flow and function in areas to a total or partial coronary occlusion in dogs. Circulation 1984;69:391-9.
33. Garlichs CDE, Zhang H, Mugge A, Daniel WG. Beta blockers reduce the release and synthesis of endothelin-1 in human endothelial cells. Eur J Clin Invest 1999;29:12.
34. Boogaerts MA, Roelant C, Temmerman J, Goossens W, Verwilghen RL. Effect of beta-blocking drugs on red cell adhesive and rheological properties. J Lab Clin Med 1983;102:899-908.
35. Eichhorn EJ, Bedotto JB, Malloy CR, Hatfiled BA, Deichman D, Brown M, et al. Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Circulation 1990;82:473-83.
36. Andersson B, Blomström-Lundquist C, Hedner T, Waagstein F. Exercise hemodynamics and myocardial metabolism during long-term betablockade in severe heart failure. J Am Coll Cardiol 1991;18:1059-66.
37. Omerovic E, Bollano E, Mobini R, Basetti M, Kujacic V, Soussi B, et al. Selective beta-1-blockade improves cardiac bioenergetics and function and decreases neuroendocrine activation in rats during early postinfarct remodeling. Biochem Biophys Res Commun 2001;281:491-8.
38. ia-proteins in patients with congestive heart failure. Eur J Clin Pharmacol 1996;51:127-32.
39. Andersson B, Hamm C, Persson S, Wikstrom G, Sinagra G, Hjalmarsson A, et al. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol 1994;23:1397-404.
40. Cleland JGF, Penell D, Ray S, Coats A, Lahiri A, Dalle Mule J, et al. Effect of carvedilol on myocardial ischaemia, hibernation and viability in patients with left ventricular dysfunction due to CAD. Eur Heart J 2002;23(Suppl. 81):517.
41. Packer M, Coats JS, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. For the Carvedilol prospective randomized cumulative study group. N Eng J Med 2001;344:1651-8.
42. Goldstein S, Fagerberg B, Hjalmarson A, Kjekshus J, Waagstein F, Wedel H, et al. Metoprolol controlled release/extended release in patients with severe heart failure:analysis of the experience in the MERIT HF study. J Am Coll Cardiol 2001;38:932-8.
43. Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, et al. Effects of ACE inhibitor enalapril on long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation 1992;86:431-8.